$BFACF
Battery Future Acquisition Corp.

2022 Q4 Form 10-K Financial Statement

#000119312523084123 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $187.1K $1.566M
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $187.1K $1.566M
YoY Change 0.85% 727.76%
Operating Profit -$1.566M
YoY Change
Interest Expense $2.977M $5.076M
YoY Change 334371.91% 570193.26%
% of Operating Profit
Other Income/Expense, Net $1.601M $22.82M
YoY Change -76.74% 231.45%
Pretax Income $4.391M $21.25M
YoY Change -31.17% 233.37%
Income Tax
% Of Pretax Income
Net Earnings $4.391M $21.25M
YoY Change -31.17% 233.37%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.10 $0.49
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $299.2K $299.2K
YoY Change -67.69% -67.69%
Cash & Equivalents $299.1K
Short-Term Investments
Other Short-Term Assets $389.6K $389.6K
YoY Change -11.05% -11.05%
Inventory
Prepaid Expenses $389.6K
Receivables
Other Receivables
Total Short-Term Assets $688.7K $688.7K
YoY Change -49.5% -49.5%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $357.0M $357.0M
YoY Change 1.44% 1.44%
Other Assets $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Assets $357.0M $357.0M
YoY Change 1.32% 1.32%
TOTAL ASSETS
Total Short-Term Assets $688.7K $688.7K
Total Long-Term Assets $357.0M $357.0M
Total Assets $357.7M $357.7M
YoY Change 1.13% 1.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $614.8K $614.8K
YoY Change 345.79% 345.79%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $626.7K $626.7K
YoY Change 318.51% 318.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.219M $2.219M
YoY Change -88.88% -88.88%
Total Long-Term Liabilities $2.219M $2.219M
YoY Change -88.88% -88.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $626.7K $626.7K
Total Long-Term Liabilities $2.219M $2.219M
Total Liabilities $2.846M $2.846M
YoY Change -85.85% -85.85%
SHAREHOLDERS EQUITY
Retained Earnings -$2.157M
YoY Change -88.23%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.156M $354.8M
YoY Change
Total Liabilities & Shareholders Equity $357.7M $357.7M
YoY Change 1.13% 1.13%

Cashflow Statement

Concept 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $4.391M $21.25M
YoY Change -31.17% 233.37%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$56.16K -$626.6K
YoY Change -93.7% -29.75%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $0.00 $0.00
YoY Change -100.0% -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -56.16K -626.6K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 0.000 0.000
Net Change In Cash -56.16K -626.6K
YoY Change -106.07% -167.69%
FREE CASH FLOW
Cash From Operating Activities -$56.16K -$626.6K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001880441
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41158
CY2022 dei Entity Registrant Name
EntityRegistrantName
BATTERY FUTURE ACQUISITION CORP.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1618517
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
777 Brickell Ave. #500-97545
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Miami
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33131
CY2022 dei City Area Code
CityAreaCode
61
CY2022 dei Local Phone Number
LocalPhoneNumber
460-545-788
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q2 dei Entity Public Float
EntityPublicFloat
342930000
CY2022 bfac Number Of Days Within Which Public Shares Shall Be Redeemed After The Last Date For Business Combination
NumberOfDaysWithinWhichPublicSharesShallBeRedeemedAfterTheLastDateForBusinessCombination
P10D
CY2022 dei Auditor Name
AuditorName
WithumSmith+Brown, PC
CY2022 dei Auditor Location
AuditorLocation
New York
CY2022 dei Auditor Firm
AuditorFirmId
100
CY2022Q4 us-gaap Cash
Cash
299149
CY2021Q4 us-gaap Cash
Cash
925758
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
389583
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
437985
CY2022Q4 us-gaap Assets Current
AssetsCurrent
688732
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1363743
CY2022Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
0
CY2021Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
414521
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
356976495
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
351900888
CY2022Q4 us-gaap Assets
Assets
357665227
CY2021Q4 us-gaap Assets
Assets
353679152
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
614839
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
137916
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11820
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11820
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
626659
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
149736
CY2022Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2219165
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
19963011
CY2022Q4 us-gaap Liabilities
Liabilities
2845824
CY2021Q4 us-gaap Liabilities
Liabilities
20112747
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
356975607
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
351900000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2157067
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18334458
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2156204
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-18333595
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
357665227
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
353679152
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1566455
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
189239
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1566455
us-gaap Operating Income Loss
OperatingIncomeLoss
-189239
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
5075607
us-gaap Investment Income Interest
InvestmentIncomeInterest
888
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17743846
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6884712
CY2022 bfac Transaction Cost
TransactionCost
0
bfac Transaction Cost
TransactionCost
321236
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
22819453
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6564364
CY2022 us-gaap Net Income Loss
NetIncomeLoss
21252998
us-gaap Net Income Loss
NetIncomeLoss
6375125
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
0
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
bfac Cash Paid In Excess Of Fair Value For Private Placement Warrants
CashPaidInExcessOfFairValueForPrivatePlacementWarrants
3083501
us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
27817221
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6375125
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-18333595
CY2022 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
5075607
CY2022 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
21252998
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2156204
CY2022 us-gaap Net Income Loss
NetIncomeLoss
21252998
us-gaap Net Income Loss
NetIncomeLoss
6375125
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
5075607
us-gaap Investment Income Interest
InvestmentIncomeInterest
888
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-17743846
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6884712
CY2022 bfac Transaction Cost
TransactionCost
0
bfac Transaction Cost
TransactionCost
321236
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-48402
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
437985
CY2022 bfac Increase Decrease Prepaid Expense Non Current
IncreaseDecreasePrepaidExpenseNonCurrent
-414521
bfac Increase Decrease Prepaid Expense Non Current
IncreaseDecreasePrepaidExpenseNonCurrent
414521
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
476923
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
137916
CY2022 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
11820
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-626609
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-892009
CY2022 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
351900000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-351900000
CY2022 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
0
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
338100000
CY2022 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
16300000
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
682233
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
353717767
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-626609
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
925758
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
925758
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299149
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
925758
CY2022 bfac Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
0
bfac Deferred Offering Costs Paid By Sponsor In Exchange For Issuance Of Ordinary Shares
DeferredOfferingCostsPaidBySponsorInExchangeForIssuanceOfOrdinaryShares
25000
CY2022 bfac Costs Paid By Sponsor In Exchange For Credit Towards The Purchase Price Of The Private Placement Warrants Purchased At Closing
CostsPaidBySponsorInExchangeForCreditTowardsThePurchasePriceOfThePrivatePlacementWarrantsPurchasedAtClosing
0
bfac Costs Paid By Sponsor In Exchange For Credit Towards The Purchase Price Of The Private Placement Warrants Purchased At Closing
CostsPaidBySponsorInExchangeForCreditTowardsThePurchasePriceOfThePrivatePlacementWarrantsPurchasedAtClosing
1498810
CY2021Q4 us-gaap Cash
Cash
979690
CY2022Q4 bfac Percentage Of Amount Of Trust Assets Of Target Company Excluding Underwriting Commission Working Capital And Taxes
PercentageOfAmountOfTrustAssetsOfTargetCompanyExcludingUnderwritingCommissionWorkingCapitalAndTaxes
0.80
CY2021Q4 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
351900000
CY2022 bfac Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2022Q4 bfac Percentage Of Public Shareholding To Be Redeemed In Case Of Non Occurrence Of Business Combination
PercentageOfPublicShareholdingToBeRedeemedInCaseOfNonOccurrenceOfBusinessCombination
1
CY2022Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q4 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2022Q4 bfac Percentage Of Public Shareholding To Be Redeemed In Case Of Non Occurrence Of Business Combination
PercentageOfPublicShareholdingToBeRedeemedInCaseOfNonOccurrenceOfBusinessCombination
1
CY2022Q4 us-gaap Cash
Cash
299149
CY2022Q4 bfac Working Capital
WorkingCapital
62073
CY2021Q4 us-gaap Cash
Cash
925758
CY2021Q4 bfac Working Capital
WorkingCapital
1214007
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;">Use of Estimates </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period<div style="letter-spacing: 0px; top: 0px;;display:inline;">s</div>. </div> <div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </div>
CY2021Q4 us-gaap Cash
Cash
925758
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Cash
Cash
299149
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022 bfac Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;;text-indent: 0px;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risk </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-indent: 0px;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit <div style="letter-spacing: 0px; top: 0px;;display:inline;">Insurance<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div>Corporation coverage limit of $250,000. <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">Any loss incurred or a lack of access to such funds could have a <div style="letter-spacing: 0px; top: 0px;;display:inline;">material </div>adverse </div></div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">effect</div></div> <div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">on the Company’s financial condition, results of operations, and cash flows. </div></div></div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 bfac Percent Of Gross Proceeds To Equity Proceeds
PercentOfGrossProceedsToEquityProceeds
0.60
CY2022Q4 bfac Warrant Redemption Price
WarrantRedemptionPrice
0.01
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
18
CY2022 us-gaap Related Party Costs
RelatedPartyCosts
0
us-gaap Related Party Costs
RelatedPartyCosts
11820
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
356976495
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
351900888
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0

Files In Submission

Name View Source Status
0001193125-23-084123-index-headers.html Edgar Link pending
0001193125-23-084123-index.html Edgar Link pending
0001193125-23-084123.txt Edgar Link pending
0001193125-23-084123-xbrl.zip Edgar Link pending
bfac-20221231.xsd Edgar Link pending
d456138d10k.htm Edgar Link pending
d456138dex311.htm Edgar Link pending
d456138dex312.htm Edgar Link pending
d456138dex321.htm Edgar Link pending
d456138dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
bfac-20221231_cal.xml Edgar Link unprocessable
bfac-20221231_def.xml Edgar Link unprocessable
bfac-20221231_lab.xml Edgar Link unprocessable
bfac-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d456138d10k_htm.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending